1.
Zentralbl Gynakol
; 103(12): 694-702, 1981.
Artigo
em Alemão
| MEDLINE
| ID: mdl-6169232
RESUMO
Changes in interferon and thymus factor as well as in cAMP levels and lymphocyte populations were recorded from patients with mammary carcinoma. They were equally recordable from those in whom no clinical tumour had been detectable at the time of postsurgical examinations as well as from patients with metastases distant from the primary tumour. The possibility for centralised disorder of immunological tumour cell defence in carcinoma patients is discussed.